Radovan Prikryl1, Hana Prikrylova Kucerova. 1. Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. radovan.prikryl@post.cz
Abstract
OBJECTIVE: Despite the development of second-generation antipsychotic drugs, treatment-resistant symptoms still represent a serious problem in schizophrenia. The aim of the present article was to review studies with repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia and draw conclusions for clinical decision making. METHOD: Literature for this review was identified by searching MEDLINE and ISI Web of Science up to the year 2011. RESULTS: Five open studies, 13 sham-controlled studies, and 2 meta-analysis and 2 review articles were included in the present paper. The effect size of the high frequency repetitive transcranial magnetic stimulation (rTMS) over the left prefrontal cortex in the treatment of negative symptoms of schizophrenia is thought to be mild to moderate (Cohen d = 0.43-0.68). CONCLUSION: Despite the promising results of some rTMS studies, the potential of rTMS for the treatment of negative symptoms is currently relatively unclear. Large clinical studies are therefore needed, especially large multicentric studies such as depression rTMS studies.
OBJECTIVE: Despite the development of second-generation antipsychotic drugs, treatment-resistant symptoms still represent a serious problem in schizophrenia. The aim of the present article was to review studies with repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia and draw conclusions for clinical decision making. METHOD: Literature for this review was identified by searching MEDLINE and ISI Web of Science up to the year 2011. RESULTS: Five open studies, 13 sham-controlled studies, and 2 meta-analysis and 2 review articles were included in the present paper. The effect size of the high frequency repetitive transcranial magnetic stimulation (rTMS) over the left prefrontal cortex in the treatment of negative symptoms of schizophrenia is thought to be mild to moderate (Cohen d = 0.43-0.68). CONCLUSION: Despite the promising results of some rTMS studies, the potential of rTMS for the treatment of negative symptoms is currently relatively unclear. Large clinical studies are therefore needed, especially large multicentric studies such as depression rTMS studies.
Authors: Takeshi Asami; Sang Hyuk Lee; Sylvain Bouix; Yogesh Rathi; Thomas J Whitford; Margaret Niznikiewicz; Paul Nestor; Robert W McCarley; Martha E Shenton; Marek Kubicki Journal: Psychiatry Res Date: 2014-02-19 Impact factor: 3.222
Authors: A Hasan; T Wobrock; B Guse; B Langguth; M Landgrebe; P Eichhammer; E Frank; J Cordes; W Wölwer; F Musso; G Winterer; W Gaebel; G Hajak; C Ohmann; P E Verde; M Rietschel; R Ahmed; W G Honer; P Dechent; B Malchow; M F U Castro; D Dwyer; C Cabral; P M Kreuzer; T B Poeppl; T Schneider-Axmann; P Falkai; N Koutsouleris Journal: Mol Psychiatry Date: 2016-10-11 Impact factor: 15.992
Authors: Mei Hong Xiu; Heng Yong Guan; Jian Min Zhao; Ke Qiang Wang; Yan Fen Pan; Xiu Ru Su; Yu Hong Wang; Jin Ming Guo; Long Jiang; Hong Yu Liu; Shi Guang Sun; Hao Ran Wu; Han Song Geng; Xiao Wen Liu; Hui Jing Yu; Bao Chun Wei; Xi Po Li; Tammy Trinh; Shu Ping Tan; Xiang Yang Zhang Journal: Schizophr Bull Date: 2020-03-17 Impact factor: 9.306